CA2422097A1 - Pressure-responsive means and associated method of manufacture - Google Patents
Pressure-responsive means and associated method of manufacture Download PDFInfo
- Publication number
- CA2422097A1 CA2422097A1 CA002422097A CA2422097A CA2422097A1 CA 2422097 A1 CA2422097 A1 CA 2422097A1 CA 002422097 A CA002422097 A CA 002422097A CA 2422097 A CA2422097 A CA 2422097A CA 2422097 A1 CA2422097 A1 CA 2422097A1
- Authority
- CA
- Canada
- Prior art keywords
- tongue
- pressure
- responsive means
- membrane
- sheet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F15—FLUID-PRESSURE ACTUATORS; HYDRAULICS OR PNEUMATICS IN GENERAL
- F15C—FLUID-CIRCUIT ELEMENTS PREDOMINANTLY USED FOR COMPUTING OR CONTROL PURPOSES
- F15C3/00—Circuit elements having moving parts
- F15C3/04—Circuit elements having moving parts using diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/007—Mechanical counters
- A61M15/0071—Mechanical counters having a display or indicator
- A61M15/0076—Mechanical counters having a display or indicator on a drum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0091—Inhalators mechanically breath-triggered
- A61M15/0096—Hindering inhalation before activation of the dispenser
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
- B29C45/14—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor incorporating preformed parts or layers, e.g. injection moulding around inserts or for coating articles
- B29C45/14336—Coating a portion of the article, e.g. the edge of the article
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/755—Membranes, diaphragms
Abstract
There is provided a pressure-responsive means (40) suitable for use in an inhaler, the pressure-responsive means (40) comprising a closed frame (42) over which is fixed a membrane (44), a tongue (46) being supported on the membrane (44). Two upstanding wings (50) are integrally moulded with the tongue (46) and incorporate square apertures (52). A method of manufacturing the pressure-responsive means (40) is also provided.
Description
Pressure-responsive Means and Associated Method of Manufacture Field of the Invention This invention relates to pressure-responsive means suitable for use in an inhaler which dispenses medication, an inhaler incorporating such a pressure-responsive means and an associated method of manufacture.
Background to the Invention Pressure-responsive means, such as those comprising diaphragms, are well known.
However where these pressure-responsive elements are intended to deflect in response to pressure differentials resulting from inhalation of air, then they are often unsatisfactory as they require relatively large pressure differentials for deflection to occur.
A person whose inhalation of breath is intended to provide this pressure differential can have difficulty in producing sufficient force to deflect the pressure-responsive element. This is particularly so in asthma inhalers used to dispense doses of medication in response to inhalation by a patient, rather than in response to a manual trigger.
It is an aim of the present invention to provide a pressure-responsive means which is sensitive to small pressure differentials, an inhaler incorporating such a pressure-responsive means and also an associated method of manufacture.
The invention is not intended to be limited to use only in the field of inhalers, but may be applicable in any field requiring a pressure-responsive means sensitive to small pressure differentials.
Summary of the Invention_ In accordance with one aspect of the present invention, there is provided a pressure-responsive means comprising a support means bearing a flexible sheet, wherein the flexible sheet carnes a tongue moveable in response to changes in pressure.
Background to the Invention Pressure-responsive means, such as those comprising diaphragms, are well known.
However where these pressure-responsive elements are intended to deflect in response to pressure differentials resulting from inhalation of air, then they are often unsatisfactory as they require relatively large pressure differentials for deflection to occur.
A person whose inhalation of breath is intended to provide this pressure differential can have difficulty in producing sufficient force to deflect the pressure-responsive element. This is particularly so in asthma inhalers used to dispense doses of medication in response to inhalation by a patient, rather than in response to a manual trigger.
It is an aim of the present invention to provide a pressure-responsive means which is sensitive to small pressure differentials, an inhaler incorporating such a pressure-responsive means and also an associated method of manufacture.
The invention is not intended to be limited to use only in the field of inhalers, but may be applicable in any field requiring a pressure-responsive means sensitive to small pressure differentials.
Summary of the Invention_ In accordance with one aspect of the present invention, there is provided a pressure-responsive means comprising a support means bearing a flexible sheet, wherein the flexible sheet carnes a tongue moveable in response to changes in pressure.
The pressure-responsive means is particularly of use within breath-operated inhalers used for dispensing medication, where movement of the tongue can be used to trigger dispensing of a dose, but is generally applicable to any field requiring a pressure-responsive means sensitive to small pressure differentials.
The support means is preferably a closed frame, such as a rectangular frame, with an entire peripheral edge of the flexible sheet fixed to the frame. The sheet is thus sealed to the frame.
The support means can be of any configuration, and thus can be oval in shape, or if appropriate, an open frame such as a U-shaped frame.
Thus the flexible sheet may be provided by a membrane further comprising a slack region, the slack region thus providing an area over which the membrane is deflectable within the frame.
The tongue preferably extends across the membrane such that an upper part of the tongue is carried by the slack region of the membrane. In such an arrangement, the upper part of the tongue deflects in response to differences in air pressure due to travel permitted by the slack region of the membrane, and the remainder of the membrane acts as a hinging means about which the upper part of the tongue pivots. There is thus no connection between the tongue and the frame, the tongue solely being carried by the membrane. The tongue is thus independently movable of the frame, The tongue may be tapered along its length, having an upper broad region and a lower narrow region, with the upper region being carried by the slack region of the membrane.
The tongue may further comprise two wings attached to one face of the tongue, the two wings each having an aperture for receiving part of a trigger means. When the pressure-responsive means is used within a breath-operated inhaler, movement of the tongue causes triggering of the trigger means due to part of the trigger means being received within the wing apertures.
The support means is preferably a closed frame, such as a rectangular frame, with an entire peripheral edge of the flexible sheet fixed to the frame. The sheet is thus sealed to the frame.
The support means can be of any configuration, and thus can be oval in shape, or if appropriate, an open frame such as a U-shaped frame.
Thus the flexible sheet may be provided by a membrane further comprising a slack region, the slack region thus providing an area over which the membrane is deflectable within the frame.
The tongue preferably extends across the membrane such that an upper part of the tongue is carried by the slack region of the membrane. In such an arrangement, the upper part of the tongue deflects in response to differences in air pressure due to travel permitted by the slack region of the membrane, and the remainder of the membrane acts as a hinging means about which the upper part of the tongue pivots. There is thus no connection between the tongue and the frame, the tongue solely being carried by the membrane. The tongue is thus independently movable of the frame, The tongue may be tapered along its length, having an upper broad region and a lower narrow region, with the upper region being carried by the slack region of the membrane.
The tongue may further comprise two wings attached to one face of the tongue, the two wings each having an aperture for receiving part of a trigger means. When the pressure-responsive means is used within a breath-operated inhaler, movement of the tongue causes triggering of the trigger means due to part of the trigger means being received within the wing apertures.
Typically the end of the tongue furthest from the hinging means deflects approximately 4 mm about the hinging means, i.e. a total deflection of 8 mm and there may be a degree of translation of the end of the tongue closest to the hinging means as a result of the tongue being carried on the membrane. Thus a translation of the hinging means within the frame may occur, this translation being of a much lesser degree than the end of the tongue furthest from the hinging means, and typically being around 0.5 mm.
The frame and tongue are preferably made from plastics material, such as polyethylene or high density polyethylene, and are substantially rigid. Typically the frame has dimensions of around 60 mm x 25 mm with a thickness of around 4 mm, with the tongue sitting on the membrane within the frame, and there being a clearance region around the tongue such that the tongue and frame are separated and do not interconnect at any point.
The membrane is preferably made of a thin flexible web of plastics material, the web having a thickness of around 10 microns. Typically the web is made of high density polyethylene which is generally inelastic. Alternatively EBA (ethylene butyl acrylate) and EMA (ethylene methyl acrylate) films may be used.
The membrane may be fixed to the frame as a result of an injection moulding process used to make the pressure-responsive means.
Typically in use the pressure-responsive means is used to seal an air passageway within a breath-operated inhaler, with inhalation by a patient and the associated pressure drop causing deflection of the tongue. The movement of the tongue can be used to trigger mechanisms outside the passageway so as to result in dispensing of a dose.
Thus in accordance with another aspect of the invention there is provided a dosing device, or inhaler, for dispensing a dose material comprising a body comprising an air passageway, a trigger mechanism and a pressure-responsive means as aforesaid comprising a support means, a flexible sheet and a tongue, wherein the pressure-responsive means is placed in sealing engagement with an end of the air passageway within the body so as to seal the trigger mechanism therefrom, and the trigger mechanism is actuated by movement of the tongue in response to pressure differential within the air passageway. When a patient requires medication, they place their mouth over one end of the air passageway so as to create a substantially air-tight seal, and inhale. This creates a pressure drop within the Nassageway. The tongue deflects in response to this change in pressure and so triggers the trigger mechanism to dispense a dose.
The trigger mechanism is preferably attached to the tongue so that movement of the tongue directly actuates the trigger mechanism without the need for intervening linkages.
Connecting the trigger mechanism to the tongue also ensures that the tongue is held in a relatively fixed position, ready for deflection on inhalation.
The pressure-responsive means may desirably form a snapfit connection with the end of the air passageway within the body so that sealing engagement between the pressure-responsive means and the air passageway is readily achieved.
In accordance with a yet further aspect of the present invention, there is provided a method of making a pressure-responsive means as aforesaid, comprising placing a sheet of material between upper and lower injection moulding tools, closing the tools together, injection moulding a support means and a tongue within the tools and providing a slack region in the sheet between the support means and the tongue.
The support means and the tongue may either be formed on the same side of the sheet, or alternatively on opposite sides.
The method may further comprise distorting the sheet by stretching to achieve plastic deformation of a region of the sheet, so as to provide the slack region.
Alternatively the method may further comprise drawing part of the sheet into the tool as forming occurs, thereby to limit the amount of stretch undergone by the sheet.
This has the advantage ofproducing a stretched sheet which is less likely to perforate during manufacture of the pressure-responsive means.
The invention will now be described, by way of example, and with reference to the accompanying drawings in which:
Figure 1 shows a cut-away view of an inhaler incorporating a pressure-responsive means in accordance with the present invention;
Figure 2 shows a vertical section through the inhaler, showing the inhaler in a pre-firing state;
Figure 3 shows a vertical section through the inhaler, showing the inhaler in a post-firing state;
Figure 4 shows a detailed perspective view of the pressure-responsive means and the trigger mechanism, before firing of a dose;
Figure 5 shows a detailed perspective view of the pressure-responsive means and the trigger mechanism after firing of a dose;
Figure 6 shows a perspective view of the pressure-responsive means;
Figure 7 shows a plan view of the pressure-responsive means;
Figure 8 shows a cross-section along line VIII-VIII of Figure 7;
Figure 9 is a series of views demonstrating movement of the pressure-responsive means;
Figure 10 is a schematic representation of a first method of moulding the pressure-responsive means;
Figure 11 is a schematic view of a drawing process used in the second method;
and Figure 12 is a sectional view of tooling used in a second method of moulding the pressure-responsive means.
Description Figures 1,2 and 3 show a breath-operated metered dose inhaler (MDI) incorporating a pressure-responsive means in accordance with the present invention. The MDI
comprises a hollow outer body 10 typically made of plastics material, which includes apertures 11, and a mouthpiece moulding 12 comprising a mouthpiece 14, stem block 16 and chassis 18. A
cover 20 for the mouthpiece is attached to the body by a cam 22 which pivots as the cover 20 is moved. The inhaler is shown in Figures 1 and 2 in a rest position awaiting firing to deliver a dose of medication from a canister 23 contained within body 10. The medication is suspended in a propellant of the hydrofluoroalkane type (HFA's).
The canister 23 is positioned within the body 10 between a canister carriage 24 and a steel bar or hook 25 forming part of a substantially u-shaped spring carriage 26 bearing two main springs 30 disposed on either side of the canister 23. In this rest position of the inhaler, the canister is relatively loose and is only held in place because a valve stem of the canister is held within a stem block 16.
The body 10 defines a holding area 32 in which a dose-actuation mechanism 34 is situated and also a conduit forming an air passage 36, at an inner end of which pressure-responsive means 40 is located in sealing engagement. The air passage is in fluid communication with apertures 11 via two small apertures 41, see Figure 2, in the wall of the conduit. The pressure-responsive means 40 comprises a closed frame 42 over which is fixed a plastics membrane 44, with a tongue 46 being supported on the membrane, and two upstanding wings 50 integrally moulded with the tongue and incorporating square apertures 52. The pressure-responsive means 40 is discussed in more detail with reference to Figures 6 to 9.
The trigger mechanism 34 comprises a trigger link 54, an intermediate link 56 and a power link 58 and is typically made as a one-piece moulding from polypropylene. The trigger link 54 is around 30mm in length, 7mm wide, lmrn thick and tapers to around 100 microns thick at its hinging point 60. Pins 62 are moulded into the link near the hinging point and sit within the square apertures of wings 50. The intermediate link 56 is around 1mm thick, tapering to 200 microns thick at its hinging point 64, and the power link 58 is around 2mm thick, tapering to around 0.5 mm thick at its hinging point 66. A biasing torsion spring 70 is held on a roll pin 72 supported in the chassis 18, the biasing torsion spring 70 being held in compression by the trigger link 54 between the chassis 18 and a mounting position 73 on the uppermost surface of the intermediate link 56.
In Figures l, 2 and 4, the triggering mechanism 34 is in the rest position and the device is ready to dispense a dose. The trigger link 54 is held in a stable over-centre position as a result of biasing torsion spring 70, and each pin 62 rests against one edge of the respective square aperture 52. The trigger link is in a substantially vertical configuration, with a first element 74 and a second element 76 subtending nearly 180° of arc. The near vertical trigger link 54 holds the intermediate link 56 and power link 58 at unstable under-centre positions.
Pin joints 80, 82, 84, 86 secure the loose ends of the mechanism within the body. The end of the second element 76 furthest from the hinging point 62 is permanently hinged to the intermediate link 56 close to the hinge 64, with end 90 of the intermediate link hinged to the power link close to the hinging point 66 of the power link. A leg of the biasing torsion spring 70 sits in a saddle 73 on the intermediate link close to the hinge 64 of the intermediate link and allows the intermediate link 56 to be, substantially straight, although slightly undercentre.
The elements forming the trigger mechanism and the pressure-responsive means are shown in detail in Figure 4, before firing of a dose.
When a patient wishes to take a dose of medication, they open cover 20 so as to access the mouthpiece 14. As the cover is opened, the cam 22 rotates, cam follower or saddle 92 moves downwards and steel bar or hook 25 is moved into engagement with the canister 23 as shown in Figure 3. As the cam continues to rotate, the bar 25 pushes the canister into the canister carriage 24 and only then does the trigger mechanism bear much of the force of the main spring, which was previously carried by the cam. In this primed position, the patient places their mouth over the mouthpiece 14 so as to create a seal and inhales.
Air is drawn in through the apertures in the air passageway wall and through the slots 11, creating a through-flow of air which produces a pressure drop of about 0.5 kPa in the device which causes the tongue of the pressure-responsive means to move. As the tongue moves in response to an intake of breath, the trigger link 54 is pulled under-centre as shown in Figures 3 and 5. An air valve could be added to the air passage to reduce the pressure drop at a given flow rate once the canister has been fired.
As the trigger link 54 moves into this under-centre position as shown in Figure 5, the biasing torsion spring 70 pushes the intermediate link 56 under-centre. The power link 58 is pulled under-centre due to the interconnection of the power link and the intermediate link, and the power link moves into a substantially V-shape. The overall height or extent of the power link is thus reduced and the two main springs held on spring carriage 26 are released to expand and urge the canister against stem block and so depress a valve stem to release a dose.
This toggle-type trigger mechanism is very sensitive, with only a small pressure drop of around O.SkPa across the pressure-responsive means 40 being required to produce a force of around O.SN to cause the trigger link 54 to move. Once a dose has been dispensed, the cover 20 is closed and the cover cam rotates to reset the power and trigger links into the rest position. A cantilever carried on saddle 92 pushes the trigger link over-centre to complete reset of the trigger mechanism.
A detailed view of the pressure-responsive means 100 when connected to the trigger mechanism is shown in Figure 6, the pressure-responsive means comprising a closed rectangular frame 102 made of polyethylene or high density polyethylene, a supporting membrane 104 of approximately 10 microns thick made of high density polyethylene and welded to the frame, and a tongue 106 fixed to and carried on the membrane.
Integral wings 110, 112 are moulded to the tongue 106, and each wing or web has a square aperture 114, 116 for receiving pin 62 of the trigger link, as already discussed. The frame 102 is capable of snapfit connection into the internal end 37 of the air passageway 36 so as to seal the passageway at one end, or can be ultrasonically welded to the internal end 37.
The membrane 104 prevents uncontrolled leaks around the tongue 106.
Typically the dimensions of the frame are around 60 mm x 30 mm, with the frame having a thickness of around 5 mm. The tongue is made of plastics material such as polyethylene and is approximately 2 mm in thickness. Both the tongue, wings and the frame are made from a plastics material which ensures that they are essentially rigid, at least to small forces.
The membrane is deformed in region 118, typically by a drawing process, so that a slack region is provided. Thus whilst the membrane is generally inelastic, i.e. not automatically returning to a position after deflection, the slack region provides flexibility allowing deflection of the tongue. As will be seen in Figure 7, the tongue 106 is held within but spaced apart from the frame 102, being supported entirely by the membrane 104.
The tongue 106 is tapered with a lower narrow end 120 being supported on a lower part of the membrane and an upper broad end 122 of the tongue being carried on a slack region 118 of the membrane. The slack region 118 allows movement of the upper end 122 of the tongue relative to the frame 102, with a lower part 124 of the membrane providing a hinging point about which the tongue 106 can pivot. The upper end 122 of the tongue can thus move backwards and forwards about the hinging point, as shown in Figure 9(c) to (e), by approximately 4 mm, i.e. 8 mm total travel. The hinging point also undergoes a certain amount of movement within the frame, but to a lesser extent of around O.Smm backwards and forwards.
A sectional view of the pressure-responsive means along line VIII-VIII of Figure 7 is shown in Figure ~.
When the pressure-responsive means, or friction-free flap, is used within an inhaler, inhalation of air by a patient through the mouthpiece causes a partial vacuum which deflects the upper region 122 of tongue 106. As the tongue moves, the trigger link attached to the tongue is pulled, so releasing the trigger mechanism and dispensing a dose. By using an extremely thin web to carry the tongue, the pressure-responsive means is responsive to very low pressures and not sensitive to manufacturing tolerances as the clearance between tongue and frame is not of such small dimension as to render the pressure-responsive means inoperable if inaccuracies in manufacturing do occur.
The pressure-responsive means may be made by two rather similar methods.
The first method will be described with reference to Figures 9(a) and (b) and Figure 10. The process used is similar to in-mould labelling, and comprises placing a film or membrane 130 of high density polyethylene of thickness 10 microns between upper and lower injection moulding tools 132, 134. The tools 132, 134 are then closed together and polyethylene injected into each tool so as to form a tongue of the pressure-responsive means within the upper tool and a frame of the pressure-responsive means within the lower tool.
The frame and tongue are thus placed on either side of the membrane, and the membrane moulded whilst the tongue is within the frame so as to avoid wrinkling the membrane.
If desired, the tongue and frame can be moulded on the same side of the membrane.
The materials chosen for the membrane and the frame and tongue are carefully selected so that the frame will weld to the membrane, and the membrane weld to the tongue.
After moulding, see Figure 9(a), the membrane is stretched at an upper region so that it yields, as seen in Figure 9(b) and the tongue is then free to move back and forth as shown in Figures 9(c)-(e). It is important that the membrane is not an elastomer as in the post yielding process it would stretch and then recover, rather than permanently stretch. It is also important to ensure that the membrane is selected from a material that will yield without perforation as otherwise performance of the pressure-responsive means is compromised.
In an alternative to purely plastic deformation of the membrane, it is possible to use a drawing process, which may be used in combination with plastic deformation.
When a drawing process is used, the method is modified such that upper and lower tool faces 140, 142 are shaped such that when the membrane is clamped I43 between them, the membrane is held in position with a pressure ring 144, see Figure 12. The tool design is such that the tongue is set at an angle to the frame, and on closing the tool, the membrane is drawn to produce the required shape. In this shape, the tongue is positioned at an angle to the frame which is greater than, or equal to, the maximum deflection which the tongue will experience in operation of the device. When the two parts 140, 142 of the tool are urged together, the membrane deforms over inclined region 146 of the tool face.
By using a continuous sheet of membrane and pulling material in from outside the tool, thinning of the membrane can be avoided so reducing the risk of perforation.
Membranes such as EBA and EMA films which are slightly elastomeric are used. This drawing process alters the shape of the membrane without altering the thickness, see Figure 11 where an undrawn membrane 150 of length L is shown in Figure 11(a) and a drawn membrane, of same total length but modified shape, is shown in Figure 11 (b). This provides a less concentrated stretch, where the local strain is lower and perforation is less likely than by just using plastic deformation as in the first method described.
The frame and tongue are preferably made from plastics material, such as polyethylene or high density polyethylene, and are substantially rigid. Typically the frame has dimensions of around 60 mm x 25 mm with a thickness of around 4 mm, with the tongue sitting on the membrane within the frame, and there being a clearance region around the tongue such that the tongue and frame are separated and do not interconnect at any point.
The membrane is preferably made of a thin flexible web of plastics material, the web having a thickness of around 10 microns. Typically the web is made of high density polyethylene which is generally inelastic. Alternatively EBA (ethylene butyl acrylate) and EMA (ethylene methyl acrylate) films may be used.
The membrane may be fixed to the frame as a result of an injection moulding process used to make the pressure-responsive means.
Typically in use the pressure-responsive means is used to seal an air passageway within a breath-operated inhaler, with inhalation by a patient and the associated pressure drop causing deflection of the tongue. The movement of the tongue can be used to trigger mechanisms outside the passageway so as to result in dispensing of a dose.
Thus in accordance with another aspect of the invention there is provided a dosing device, or inhaler, for dispensing a dose material comprising a body comprising an air passageway, a trigger mechanism and a pressure-responsive means as aforesaid comprising a support means, a flexible sheet and a tongue, wherein the pressure-responsive means is placed in sealing engagement with an end of the air passageway within the body so as to seal the trigger mechanism therefrom, and the trigger mechanism is actuated by movement of the tongue in response to pressure differential within the air passageway. When a patient requires medication, they place their mouth over one end of the air passageway so as to create a substantially air-tight seal, and inhale. This creates a pressure drop within the Nassageway. The tongue deflects in response to this change in pressure and so triggers the trigger mechanism to dispense a dose.
The trigger mechanism is preferably attached to the tongue so that movement of the tongue directly actuates the trigger mechanism without the need for intervening linkages.
Connecting the trigger mechanism to the tongue also ensures that the tongue is held in a relatively fixed position, ready for deflection on inhalation.
The pressure-responsive means may desirably form a snapfit connection with the end of the air passageway within the body so that sealing engagement between the pressure-responsive means and the air passageway is readily achieved.
In accordance with a yet further aspect of the present invention, there is provided a method of making a pressure-responsive means as aforesaid, comprising placing a sheet of material between upper and lower injection moulding tools, closing the tools together, injection moulding a support means and a tongue within the tools and providing a slack region in the sheet between the support means and the tongue.
The support means and the tongue may either be formed on the same side of the sheet, or alternatively on opposite sides.
The method may further comprise distorting the sheet by stretching to achieve plastic deformation of a region of the sheet, so as to provide the slack region.
Alternatively the method may further comprise drawing part of the sheet into the tool as forming occurs, thereby to limit the amount of stretch undergone by the sheet.
This has the advantage ofproducing a stretched sheet which is less likely to perforate during manufacture of the pressure-responsive means.
The invention will now be described, by way of example, and with reference to the accompanying drawings in which:
Figure 1 shows a cut-away view of an inhaler incorporating a pressure-responsive means in accordance with the present invention;
Figure 2 shows a vertical section through the inhaler, showing the inhaler in a pre-firing state;
Figure 3 shows a vertical section through the inhaler, showing the inhaler in a post-firing state;
Figure 4 shows a detailed perspective view of the pressure-responsive means and the trigger mechanism, before firing of a dose;
Figure 5 shows a detailed perspective view of the pressure-responsive means and the trigger mechanism after firing of a dose;
Figure 6 shows a perspective view of the pressure-responsive means;
Figure 7 shows a plan view of the pressure-responsive means;
Figure 8 shows a cross-section along line VIII-VIII of Figure 7;
Figure 9 is a series of views demonstrating movement of the pressure-responsive means;
Figure 10 is a schematic representation of a first method of moulding the pressure-responsive means;
Figure 11 is a schematic view of a drawing process used in the second method;
and Figure 12 is a sectional view of tooling used in a second method of moulding the pressure-responsive means.
Description Figures 1,2 and 3 show a breath-operated metered dose inhaler (MDI) incorporating a pressure-responsive means in accordance with the present invention. The MDI
comprises a hollow outer body 10 typically made of plastics material, which includes apertures 11, and a mouthpiece moulding 12 comprising a mouthpiece 14, stem block 16 and chassis 18. A
cover 20 for the mouthpiece is attached to the body by a cam 22 which pivots as the cover 20 is moved. The inhaler is shown in Figures 1 and 2 in a rest position awaiting firing to deliver a dose of medication from a canister 23 contained within body 10. The medication is suspended in a propellant of the hydrofluoroalkane type (HFA's).
The canister 23 is positioned within the body 10 between a canister carriage 24 and a steel bar or hook 25 forming part of a substantially u-shaped spring carriage 26 bearing two main springs 30 disposed on either side of the canister 23. In this rest position of the inhaler, the canister is relatively loose and is only held in place because a valve stem of the canister is held within a stem block 16.
The body 10 defines a holding area 32 in which a dose-actuation mechanism 34 is situated and also a conduit forming an air passage 36, at an inner end of which pressure-responsive means 40 is located in sealing engagement. The air passage is in fluid communication with apertures 11 via two small apertures 41, see Figure 2, in the wall of the conduit. The pressure-responsive means 40 comprises a closed frame 42 over which is fixed a plastics membrane 44, with a tongue 46 being supported on the membrane, and two upstanding wings 50 integrally moulded with the tongue and incorporating square apertures 52. The pressure-responsive means 40 is discussed in more detail with reference to Figures 6 to 9.
The trigger mechanism 34 comprises a trigger link 54, an intermediate link 56 and a power link 58 and is typically made as a one-piece moulding from polypropylene. The trigger link 54 is around 30mm in length, 7mm wide, lmrn thick and tapers to around 100 microns thick at its hinging point 60. Pins 62 are moulded into the link near the hinging point and sit within the square apertures of wings 50. The intermediate link 56 is around 1mm thick, tapering to 200 microns thick at its hinging point 64, and the power link 58 is around 2mm thick, tapering to around 0.5 mm thick at its hinging point 66. A biasing torsion spring 70 is held on a roll pin 72 supported in the chassis 18, the biasing torsion spring 70 being held in compression by the trigger link 54 between the chassis 18 and a mounting position 73 on the uppermost surface of the intermediate link 56.
In Figures l, 2 and 4, the triggering mechanism 34 is in the rest position and the device is ready to dispense a dose. The trigger link 54 is held in a stable over-centre position as a result of biasing torsion spring 70, and each pin 62 rests against one edge of the respective square aperture 52. The trigger link is in a substantially vertical configuration, with a first element 74 and a second element 76 subtending nearly 180° of arc. The near vertical trigger link 54 holds the intermediate link 56 and power link 58 at unstable under-centre positions.
Pin joints 80, 82, 84, 86 secure the loose ends of the mechanism within the body. The end of the second element 76 furthest from the hinging point 62 is permanently hinged to the intermediate link 56 close to the hinge 64, with end 90 of the intermediate link hinged to the power link close to the hinging point 66 of the power link. A leg of the biasing torsion spring 70 sits in a saddle 73 on the intermediate link close to the hinge 64 of the intermediate link and allows the intermediate link 56 to be, substantially straight, although slightly undercentre.
The elements forming the trigger mechanism and the pressure-responsive means are shown in detail in Figure 4, before firing of a dose.
When a patient wishes to take a dose of medication, they open cover 20 so as to access the mouthpiece 14. As the cover is opened, the cam 22 rotates, cam follower or saddle 92 moves downwards and steel bar or hook 25 is moved into engagement with the canister 23 as shown in Figure 3. As the cam continues to rotate, the bar 25 pushes the canister into the canister carriage 24 and only then does the trigger mechanism bear much of the force of the main spring, which was previously carried by the cam. In this primed position, the patient places their mouth over the mouthpiece 14 so as to create a seal and inhales.
Air is drawn in through the apertures in the air passageway wall and through the slots 11, creating a through-flow of air which produces a pressure drop of about 0.5 kPa in the device which causes the tongue of the pressure-responsive means to move. As the tongue moves in response to an intake of breath, the trigger link 54 is pulled under-centre as shown in Figures 3 and 5. An air valve could be added to the air passage to reduce the pressure drop at a given flow rate once the canister has been fired.
As the trigger link 54 moves into this under-centre position as shown in Figure 5, the biasing torsion spring 70 pushes the intermediate link 56 under-centre. The power link 58 is pulled under-centre due to the interconnection of the power link and the intermediate link, and the power link moves into a substantially V-shape. The overall height or extent of the power link is thus reduced and the two main springs held on spring carriage 26 are released to expand and urge the canister against stem block and so depress a valve stem to release a dose.
This toggle-type trigger mechanism is very sensitive, with only a small pressure drop of around O.SkPa across the pressure-responsive means 40 being required to produce a force of around O.SN to cause the trigger link 54 to move. Once a dose has been dispensed, the cover 20 is closed and the cover cam rotates to reset the power and trigger links into the rest position. A cantilever carried on saddle 92 pushes the trigger link over-centre to complete reset of the trigger mechanism.
A detailed view of the pressure-responsive means 100 when connected to the trigger mechanism is shown in Figure 6, the pressure-responsive means comprising a closed rectangular frame 102 made of polyethylene or high density polyethylene, a supporting membrane 104 of approximately 10 microns thick made of high density polyethylene and welded to the frame, and a tongue 106 fixed to and carried on the membrane.
Integral wings 110, 112 are moulded to the tongue 106, and each wing or web has a square aperture 114, 116 for receiving pin 62 of the trigger link, as already discussed. The frame 102 is capable of snapfit connection into the internal end 37 of the air passageway 36 so as to seal the passageway at one end, or can be ultrasonically welded to the internal end 37.
The membrane 104 prevents uncontrolled leaks around the tongue 106.
Typically the dimensions of the frame are around 60 mm x 30 mm, with the frame having a thickness of around 5 mm. The tongue is made of plastics material such as polyethylene and is approximately 2 mm in thickness. Both the tongue, wings and the frame are made from a plastics material which ensures that they are essentially rigid, at least to small forces.
The membrane is deformed in region 118, typically by a drawing process, so that a slack region is provided. Thus whilst the membrane is generally inelastic, i.e. not automatically returning to a position after deflection, the slack region provides flexibility allowing deflection of the tongue. As will be seen in Figure 7, the tongue 106 is held within but spaced apart from the frame 102, being supported entirely by the membrane 104.
The tongue 106 is tapered with a lower narrow end 120 being supported on a lower part of the membrane and an upper broad end 122 of the tongue being carried on a slack region 118 of the membrane. The slack region 118 allows movement of the upper end 122 of the tongue relative to the frame 102, with a lower part 124 of the membrane providing a hinging point about which the tongue 106 can pivot. The upper end 122 of the tongue can thus move backwards and forwards about the hinging point, as shown in Figure 9(c) to (e), by approximately 4 mm, i.e. 8 mm total travel. The hinging point also undergoes a certain amount of movement within the frame, but to a lesser extent of around O.Smm backwards and forwards.
A sectional view of the pressure-responsive means along line VIII-VIII of Figure 7 is shown in Figure ~.
When the pressure-responsive means, or friction-free flap, is used within an inhaler, inhalation of air by a patient through the mouthpiece causes a partial vacuum which deflects the upper region 122 of tongue 106. As the tongue moves, the trigger link attached to the tongue is pulled, so releasing the trigger mechanism and dispensing a dose. By using an extremely thin web to carry the tongue, the pressure-responsive means is responsive to very low pressures and not sensitive to manufacturing tolerances as the clearance between tongue and frame is not of such small dimension as to render the pressure-responsive means inoperable if inaccuracies in manufacturing do occur.
The pressure-responsive means may be made by two rather similar methods.
The first method will be described with reference to Figures 9(a) and (b) and Figure 10. The process used is similar to in-mould labelling, and comprises placing a film or membrane 130 of high density polyethylene of thickness 10 microns between upper and lower injection moulding tools 132, 134. The tools 132, 134 are then closed together and polyethylene injected into each tool so as to form a tongue of the pressure-responsive means within the upper tool and a frame of the pressure-responsive means within the lower tool.
The frame and tongue are thus placed on either side of the membrane, and the membrane moulded whilst the tongue is within the frame so as to avoid wrinkling the membrane.
If desired, the tongue and frame can be moulded on the same side of the membrane.
The materials chosen for the membrane and the frame and tongue are carefully selected so that the frame will weld to the membrane, and the membrane weld to the tongue.
After moulding, see Figure 9(a), the membrane is stretched at an upper region so that it yields, as seen in Figure 9(b) and the tongue is then free to move back and forth as shown in Figures 9(c)-(e). It is important that the membrane is not an elastomer as in the post yielding process it would stretch and then recover, rather than permanently stretch. It is also important to ensure that the membrane is selected from a material that will yield without perforation as otherwise performance of the pressure-responsive means is compromised.
In an alternative to purely plastic deformation of the membrane, it is possible to use a drawing process, which may be used in combination with plastic deformation.
When a drawing process is used, the method is modified such that upper and lower tool faces 140, 142 are shaped such that when the membrane is clamped I43 between them, the membrane is held in position with a pressure ring 144, see Figure 12. The tool design is such that the tongue is set at an angle to the frame, and on closing the tool, the membrane is drawn to produce the required shape. In this shape, the tongue is positioned at an angle to the frame which is greater than, or equal to, the maximum deflection which the tongue will experience in operation of the device. When the two parts 140, 142 of the tool are urged together, the membrane deforms over inclined region 146 of the tool face.
By using a continuous sheet of membrane and pulling material in from outside the tool, thinning of the membrane can be avoided so reducing the risk of perforation.
Membranes such as EBA and EMA films which are slightly elastomeric are used. This drawing process alters the shape of the membrane without altering the thickness, see Figure 11 where an undrawn membrane 150 of length L is shown in Figure 11(a) and a drawn membrane, of same total length but modified shape, is shown in Figure 11 (b). This provides a less concentrated stretch, where the local strain is lower and perforation is less likely than by just using plastic deformation as in the first method described.
Claims (16)
1. A pressure-responsive means comprising a support means bearing a flexible sheet, wherein the flexible sheet carries a tongue moveable in response to changes in pressure.
2. A pressure-responsive means according to claim 1, wherein the support means is a closed frame with an entire peripheral edge of the flexible sheet fixed to the frame.
3. A pressure-responsive means according to claim 1 or claim 2, wherein the flexible sheet is provided by a membrane further comprising a slack region, the slack region providing an area over which the membrane is deflectable within the frame.
4. A pressure-responsive means according to claim 3, wherein the tongue extends across the membrane such that an upper part of the tongue is carried by the slack region of the membrane.
5. A pressure-responsive means according to claim 4, wherein the tongue is tapered along its length, having an upper broad region and a lower narrow region, with the upper broad region being carried by the slack region of the membrane.
6. A pressure-responsive means according to any of the preceding claims, wherein the tongue further comprises two wings attached to one face of the tongue, the two wings each having an aperture for receiving part of a trigger means.
7. A pressure-responsive means according to any of the preceding claims, wherein the frame and tongue are made from plastics material and are substantially rigid.
8. A pressure-responsive means according to any of the preceding claims, wherein the tongue sits on the membrane within the frame, and there is a clearance region around the tongue such that the tongue and frame are separated.
9. A pressure-responsive means according to any of the preceding claims, wherein the membrane is made of a thin flexible web of plastics material, the web having a thickness of around 10 microns.
10. A dosing device, or inhaler, for dispensing a dose material comprising a body containing an air passageway, a trigger mechanism and a pressure-responsive means comprising a support means bearing a flexible sheet which carries a tongue moveable in response to change in pressure, wherein the pressure-responsive means is placed in sealing engagement with an end of the air passageway within the body so as to seal the trigger mechanism therefrom, and the trigger mechanism is actuated by movement of the tongue in response to pressure differential within the air passageway.
11. A dosing device according to claim 10, wherein the trigger mechanism is attached to the tongue so that movement of the tongue directly actuates the trigger mechanism.
12. A dosing device according to claim 11, wherein the pressure-responsive means forms a snapfit connection with the end of the air passageway within the body.
13. A method of making a pressure-responsive means according to any of claims 1 to 9, comprising placing a sheet of material between upper and lower injection moulding tools, closing the tools together, injection moulding a support means and a tongue within the tools and providing a slack region in the sheet between the support means and the tongue.
14. A method according to claim 13, wherein the support means and the tongue are either formed on the same side of the sheet, or on opposite sides.
15. A method according to claim 13 or claim 14, wherein the method further comprises distorting the sheet by stretching to achieve plastic deformation of a region of the sheet, so as to provide the slack region.
16. A method according to claim 13 or claim 14, wherein the method further comprises drawing part of the sheet into the tool as forming occurs, thereby to limit the amount of stretch undergone by the sheet.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0023845.1A GB0023845D0 (en) | 2000-09-29 | 2000-09-29 | Dosing device |
| GB0023845.1 | 2000-09-29 | ||
| GB0028444A GB0028444D0 (en) | 2000-11-22 | 2000-11-22 | Pressure-responsive means and associated method of manufacture |
| GB0028444.8 | 2000-11-22 | ||
| PCT/GB2001/004241 WO2002026300A1 (en) | 2000-09-29 | 2001-09-24 | Pressure-responsive means and associated method of manufacture |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2422097A1 true CA2422097A1 (en) | 2002-04-04 |
Family
ID=26245073
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002422097A Abandoned CA2422097A1 (en) | 2000-09-29 | 2001-09-24 | Pressure-responsive means and associated method of manufacture |
| CA002422129A Abandoned CA2422129A1 (en) | 2000-09-29 | 2001-09-24 | Dosing device |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002422129A Abandoned CA2422129A1 (en) | 2000-09-29 | 2001-09-24 | Dosing device |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7093594B2 (en) |
| EP (2) | EP1320397B1 (en) |
| JP (1) | JP4875826B2 (en) |
| AU (2) | AU2001287924A1 (en) |
| CA (2) | CA2422097A1 (en) |
| DE (2) | DE60141149D1 (en) |
| ES (2) | ES2261466T3 (en) |
| WO (2) | WO2002026300A1 (en) |
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
| FR2834277B1 (en) * | 2001-12-28 | 2004-06-11 | Valois Sa | FLUID PRODUCT DISPENSING DEVICE |
| JP4681231B2 (en) | 2002-03-20 | 2011-05-11 | マンカインド コーポレイション | Inhaler |
| GB2401321B (en) | 2002-03-22 | 2005-12-07 | Clinical Designs Ltd | Can fixture |
| GB2398254B (en) | 2003-02-11 | 2005-12-07 | Bespak Plc | Dispensing Apparatus |
| GB2398503A (en) * | 2003-02-11 | 2004-08-25 | Bespak Plc | Inhaler with removable mouthpiece |
| GB0304000D0 (en) * | 2003-02-21 | 2003-03-26 | Clinical Designs Ltd | Dispenser |
| GB0315509D0 (en) * | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
| GB0327112D0 (en) | 2003-11-21 | 2003-12-24 | Clincial Designs Ltd | Dispenser and reservoir |
| GB0328859D0 (en) | 2003-12-12 | 2004-01-14 | Clinical Designs Ltd | Dispenser and counter |
| WO2005079727A2 (en) * | 2004-02-16 | 2005-09-01 | Glaxo Group Limited | Counter for use with a medicament dispenser |
| BRPI0514263B8 (en) | 2004-08-20 | 2021-05-25 | Mannkind Corp | method for the synthesis of n-protected bis-3,6-[4-aminobutyl]-2,5-diketopiperazine n-protected |
| KR101306384B1 (en) | 2004-08-23 | 2013-09-09 | 맨카인드 코포레이션 | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery |
| GB0425518D0 (en) | 2004-11-19 | 2004-12-22 | Clinical Designs Ltd | Substance source |
| GB0428204D0 (en) | 2004-12-23 | 2005-01-26 | Clinical Designs Ltd | Medicament container |
| FR2883400B1 (en) * | 2005-03-16 | 2007-06-15 | Valois Sas | DOSAGE INDICATING DEVICE FOR DISPENSING FLUID OR PULVERULENT PRODUCTS |
| GB0518400D0 (en) | 2005-09-09 | 2005-10-19 | Clinical Designs Ltd | Dispenser |
| EP1928423B1 (en) | 2005-09-14 | 2015-12-09 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
| WO2007098500A2 (en) | 2006-02-22 | 2007-08-30 | Mannkind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| US8225790B2 (en) * | 2007-01-02 | 2012-07-24 | Astrazeneca Ab | Inhaler 624 |
| EP2197524B1 (en) * | 2007-08-21 | 2016-09-28 | Glaxo Group Limited | Drug dispenser |
| US8251876B2 (en) * | 2008-04-22 | 2012-08-28 | Hill-Rom Services, Inc. | Breathing exercise apparatus |
| CA2982550C (en) | 2008-06-13 | 2020-08-25 | Mannkind Corporation | A dry powder inhaler and system for drug delivery |
| US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
| CN102065942B (en) | 2008-06-20 | 2013-12-11 | 曼金德公司 | An interactive apparatus and method for real-time profiling of inhalation efforts |
| TWI494123B (en) | 2008-08-11 | 2015-08-01 | Mannkind Corp | Use of ultrarapid acting insulin |
| US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
| GB0904059D0 (en) | 2009-03-10 | 2009-04-22 | Euro Celtique Sa | Counter |
| GB0904040D0 (en) | 2009-03-10 | 2009-04-22 | Euro Celtique Sa | Counter |
| PL2405963T3 (en) | 2009-03-11 | 2014-04-30 | Mannkind Corp | Apparatus, system and method for measuring resistance of an inhaler |
| ES2943333T3 (en) | 2009-06-12 | 2023-06-12 | Mannkind Corp | Diketopiperazine microparticles with defined surface areas |
| EP2461858B1 (en) | 2009-08-07 | 2020-04-22 | Kind Consumer Limited | An inhaler |
| EP2496295A1 (en) | 2009-11-03 | 2012-09-12 | MannKind Corporation | An apparatus and method for simulating inhalation efforts |
| AU2011271097B2 (en) | 2010-06-21 | 2014-11-27 | Mannkind Corporation | Dry powder drug delivery system and methods |
| CN103826988B (en) | 2011-04-01 | 2016-03-09 | 曼金德公司 | For the blister package of pharmaceutical kit |
| WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
| JP6018640B2 (en) | 2011-10-24 | 2016-11-02 | マンカインド コーポレイション | Analgesic composition effective for alleviating pain, and dry powder and dry powder drug delivery system comprising the composition |
| GB201118845D0 (en) * | 2011-11-01 | 2011-12-14 | Euro Celtique Sa | Dispenser |
| US9180271B2 (en) | 2012-03-05 | 2015-11-10 | Hill-Rom Services Pte. Ltd. | Respiratory therapy device having standard and oscillatory PEP with nebulizer |
| US9802012B2 (en) | 2012-07-12 | 2017-10-31 | Mannkind Corporation | Dry powder drug delivery system and methods |
| WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
| KR102391750B1 (en) | 2013-03-15 | 2022-04-28 | 맨카인드 코포레이션 | Microcrystalline diketopiperazine compositions and methods |
| CN105451716A (en) | 2013-07-18 | 2016-03-30 | 曼金德公司 | Heat-stable dry powder pharmaceutical compositions and methods |
| US11446127B2 (en) | 2013-08-05 | 2022-09-20 | Mannkind Corporation | Insufflation apparatus and methods |
| US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
| MA40180B1 (en) * | 2014-06-30 | 2019-08-30 | Chiesi Farm Spa | Flap for the inhalation-actuated mechanism of a dry powder inhaler |
| US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
| GB201702407D0 (en) * | 2017-02-14 | 2017-03-29 | Norton (Waterford) Ltd | Inhalers and related methods |
| EP3693044A1 (en) * | 2019-02-07 | 2020-08-12 | Koninklijke Philips N.V. | Breath actuated inhalers |
| CN117621386B (en) * | 2024-01-25 | 2024-03-29 | 新源(福建)塑胶有限公司 | Injection molding device suitable for plastic product preparation |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3590694A (en) * | 1968-11-01 | 1971-07-06 | Foxboro Co | Pressure device having layered construction and pivoting seal with operator |
| US3565070A (en) | 1969-02-28 | 1971-02-23 | Riker Laboratories Inc | Inhalation actuable aerosol dispenser |
| NO134730L (en) * | 1971-07-19 | 1900-01-01 | ||
| JPS52122758A (en) * | 1976-04-07 | 1977-10-15 | Daicel Chem Ind Ltd | Diaphgram for pressure regulator and preparation |
| EP0045419B1 (en) | 1980-08-04 | 1984-10-17 | FISONS plc | Inhalation device for administering medicaments |
| GB8328808D0 (en) * | 1983-10-28 | 1983-11-30 | Riker Laboratories Inc | Inhalation responsive dispensers |
| US5133343A (en) * | 1985-08-09 | 1992-07-28 | Johnson Iv John J | Apparatus for supporting an inhaler |
| US5119806A (en) * | 1987-05-12 | 1992-06-09 | Glaxo Inc. | Inhalation device |
| US5031610A (en) * | 1987-05-12 | 1991-07-16 | Glaxo Inc. | Inhalation device |
| US4955371A (en) * | 1989-05-08 | 1990-09-11 | Transtech Scientific, Inc. | Disposable inhalation activated, aerosol device for pulmonary medicine |
| GB8919131D0 (en) | 1989-08-23 | 1989-10-04 | Riker Laboratories Inc | Inhaler |
| FR2658081B1 (en) * | 1990-02-09 | 1995-06-30 | Pesenti Yvan | AUTOMATION AND SYNCHRONIZATION DEVICE FOR AEROSOL APPARATUS WITH DOSING PUMP. |
| US5060643A (en) * | 1990-08-07 | 1991-10-29 | Tenax Corporation | Breath-activated inhalation device |
| US5507281A (en) * | 1990-08-30 | 1996-04-16 | Boehringer Ingelheim Kg | Device for initiating a mechanical switching operation in synchronism with the breathing |
| GB9020555D0 (en) * | 1990-09-20 | 1990-10-31 | Bespak Plc | Dispensing apparatus |
| US5027808A (en) * | 1990-10-31 | 1991-07-02 | Tenax Corporation | Breath-activated inhalation device |
| GB9024760D0 (en) * | 1990-11-14 | 1991-01-02 | Riker Laboratories Inc | Inhalation device and medicament carrier |
| GB9025654D0 (en) * | 1990-11-26 | 1991-01-09 | Riker Laboratories Inc | Device |
| GB9026191D0 (en) * | 1990-12-01 | 1991-01-16 | Harris Pharma Ltd | Breath actuated dispensing device |
| US5217004A (en) | 1990-12-13 | 1993-06-08 | Tenax Corporation | Inhalation actuated dispensing apparatus |
| EP0558787A1 (en) * | 1992-03-06 | 1993-09-08 | Honeywell B.V. | Method for manufacturing membranes |
| WO1993018812A1 (en) * | 1992-03-25 | 1993-09-30 | Tebro S.A. | Powder jet dispenser for medicament inhalation therapies |
| GB9217545D0 (en) * | 1992-08-18 | 1992-09-30 | Minnesota Mining & Mfg | Inhalation device |
| WO1996028367A2 (en) * | 1995-03-10 | 1996-09-19 | Minnesota Mining And Manufacturing Company | Aerosol valves |
| US6357442B1 (en) * | 1995-06-08 | 2002-03-19 | Innovative Devices, Llc | Inhalation actuated device for use with metered dose inhalers (MDIS) |
| US5826571A (en) * | 1995-06-08 | 1998-10-27 | Innovative Devices, Llc | Device for use with metered dose inhalers (MDIS) |
| FR2747311B1 (en) * | 1996-04-10 | 1998-08-14 | Pf Medicament | POWDER AND COMPRESSED AIR INHALER |
| WO1998052634A1 (en) * | 1997-05-23 | 1998-11-26 | Pa Knowledge Limited | Inhaler mechanism |
| NZ504021A (en) * | 1997-10-17 | 2003-04-29 | Systemic Pulmonary Delivery Lt | Method and apparatus for delivering aerosolized medication having air discharged through air tube directly into plume of aerosolized medication |
| US6142339A (en) * | 1998-01-16 | 2000-11-07 | 1263152 Ontario Inc. | Aerosol dispensing device |
| GB2344535B (en) | 1998-12-11 | 2000-10-18 | Bespak Plc | Inhalation apparatus |
| GB2344534B (en) | 1998-12-11 | 2000-10-18 | Bespak Plc | Inhalation apparatus |
| GB0006525D0 (en) * | 2000-03-18 | 2000-05-10 | Astrazeneca Uk Ltd | Inhaler |
-
2001
- 2001-09-24 EP EP01969966A patent/EP1320397B1/en not_active Expired - Lifetime
- 2001-09-24 WO PCT/GB2001/004241 patent/WO2002026300A1/en active IP Right Grant
- 2001-09-24 ES ES01967551T patent/ES2261466T3/en not_active Expired - Lifetime
- 2001-09-24 DE DE60141149T patent/DE60141149D1/en not_active Expired - Lifetime
- 2001-09-24 AU AU2001287924A patent/AU2001287924A1/en not_active Abandoned
- 2001-09-24 JP JP2002530130A patent/JP4875826B2/en not_active Expired - Fee Related
- 2001-09-24 DE DE60119139T patent/DE60119139T2/en not_active Expired - Lifetime
- 2001-09-24 ES ES01969966T patent/ES2336544T3/en not_active Expired - Lifetime
- 2001-09-24 CA CA002422097A patent/CA2422097A1/en not_active Abandoned
- 2001-09-24 AU AU2001290087A patent/AU2001290087A1/en not_active Abandoned
- 2001-09-24 WO PCT/GB2001/004249 patent/WO2002026301A1/en active Application Filing
- 2001-09-24 CA CA002422129A patent/CA2422129A1/en not_active Abandoned
- 2001-09-24 EP EP01967551A patent/EP1320395B1/en not_active Expired - Lifetime
- 2001-09-24 US US10/398,066 patent/US7093594B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2422129A1 (en) | 2002-04-04 |
| JP4875826B2 (en) | 2012-02-15 |
| DE60119139T2 (en) | 2007-06-14 |
| DE60141149D1 (en) | 2010-03-11 |
| EP1320397B1 (en) | 2010-01-20 |
| US7093594B2 (en) | 2006-08-22 |
| WO2002026300A1 (en) | 2002-04-04 |
| EP1320395A1 (en) | 2003-06-25 |
| AU2001287924A1 (en) | 2002-04-08 |
| JP2004519268A (en) | 2004-07-02 |
| EP1320397A1 (en) | 2003-06-25 |
| EP1320395B1 (en) | 2006-04-26 |
| ES2261466T3 (en) | 2006-11-16 |
| WO2002026301A1 (en) | 2002-04-04 |
| DE60119139D1 (en) | 2006-06-01 |
| US20040025870A1 (en) | 2004-02-12 |
| AU2001290087A1 (en) | 2002-04-08 |
| ES2336544T3 (en) | 2010-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1320395B1 (en) | Pressure-responsive means and associated method of manufacture | |
| US7896001B2 (en) | Pressure-responsive device and associated method of manufacture | |
| KR100528375B1 (en) | Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber | |
| AU2004257456B2 (en) | Inhaler apparatus | |
| EP2461857B1 (en) | An inhaler | |
| CA2403225C (en) | An inhalation actuated device | |
| CA2417575A1 (en) | Dispenser | |
| EP1008361A2 (en) | Inhalation apparatus | |
| EP1894598B1 (en) | Liquid coinfusion unit | |
| AU2004212768B2 (en) | Dispenser | |
| JP2004520092A (en) | Pressure response means and related manufacturing method | |
| GB2084662A (en) | Syringe | |
| US20240123169A1 (en) | Breath actuated inhaler | |
| JPS6237027Y2 (en) | ||
| AU2001250806B2 (en) | An inhalation actuated device | |
| AU2001250806A1 (en) | An inhalation actuated device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |